RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Role of the CMC Regulatory Strategist in Due Diligence

Role of the CMC Regulatory Strategist in Due Diligence

Posted 01 July 2009

A pharmaceutical or biologic due diligence exercise is a matchmaking process between two companies. It is undertaken to explore a potential deal driven by one company's need for another's medicinal product, medical device or technology, or in some cases, the other company in its entirety.

 

© 2022 Regulatory Affairs Professionals Society.